Stefan H. Mueller

Stefan H. Mueller

Auto-generated profile, based on publicly available information

Stefan H. Mueller

Molecular Horizons, School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, Australia

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Molecular Cell
Verified
Journal Article
Closed access
JLJacob Lewis
Jacob Lewis
LSLisanne M. Spenkelink
Lisanne M. Spenkelink
GSGrant D. Schauer
Grant D. Schauer
OYOlga Yurieva
Olga Yurieva
SMStefan H. Mueller
Stefan H. Mueller
AOAntoine M. Van Oijen
Antoine M. Van Oijen

16 September 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
KWKelsey S. Whinn
Kelsey S. Whinn
GKGurleen Kaur
Gurleen Kaur
JLJacob Lewis
Jacob Lewis
GSGrant D. Schauer
Grant D. Schauer
SMStefan H. Mueller
Stefan H. Mueller
Harshad GhodkeHarshad Ghodke
Harshad Ghodke
Limited experimental tools are available to study the consequences of collisions between DNA-bound molecular machines. Here, we repurpose a catalytically inactivated Cas9 (dCas9) construct as a generic, novel, targetable protein–DNA roadblock for studying mechanisms underlying enzymatic activities on DNA substrates in vitro. We illustrate the broad utility of this tool by demonstrating replication fork arrest by the specifically bound dCas9–guideRNA complex to arrest viral, bacterial and eukaryotic replication forks in vitro.

16 November 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
GSGrant D. Schauer
Grant D. Schauer
LSLisanne M. Spenkelink
Lisanne M. Spenkelink
JLJacob Lewis
Jacob Lewis
OYOlga Yurieva
Olga Yurieva
SMStefan H. Mueller
Stefan H. Mueller
MOMichael E. O’donnell
Michael E. O’donnell
Efficient and faithful replication of the genome is essential to maintain genome stability. Replication is carried out by a multiprotein complex called the replisome, which encounters numerous obstacles to its progression. Failure to bypass these obstacles results in genome instability and may facilitate errors leading to disease. Cells use accessory helicases that help the replisome bypass difficult barriers. All eukaryotes contain the accessory helicase Pif1, which tracks in a 5′–3′ direction on single-stranded DNA and plays a role in genome maintenance processes. Here, we reveal a previously unknown role for Pif1 in replication barrier bypass. We use an in vitro reconstituted Saccharomyces cerevisiae replisome to demonstrate that Pif1 enables the replisome to bypass an inactive (i.e., dead) Cas9 (dCas9) R-loop barrier. Interestingly, dCas9 R-loops targeted to either strand are bypassed with similar efficiency. Furthermore, we employed a single-molecule fluorescence visualization technique to show that Pif1 facilitates this bypass by enabling the simultaneous removal of the dCas9 protein and the R-loop. We propose that Pif1 is a general displacement helicase for replication bypass of both R-loops and protein blocks. Significance The replisome machine that duplicates the DNA genome encounters a variety of blocks to replication, such as DNA bound proteins, R-loops, and DNA lesions. Studies in bacterial systems demonstrate that replisome advance through blocks is facilitated by an accessory monomeric helicase that acts on the opposite strand from the replicative hexameric helicase. This report examines this issue in a eukaryotic system, using Pif1, a monomeric helicase that acts on the opposite strand from the replicative CMG helicase. The report shows that an inactive “dead” Cas9 (dCas9) protein R-loop block arrests the replisome, but Pif1 enables replisome bypass of the dCas9 R-loop block. Hence, use of monomeric helicases may have evolved to aid replisome bypass of protein-DNA and protein-bound R-loop blocks.

1 March 2020 in Analytical Biochemistry
Verified
Journal Article
Closed access
SMStefan H. Mueller
Stefan H. Mueller
LSLisanne M. Spenkelink
Lisanne M. Spenkelink
AOAntoine M. Van Oijen
Antoine M. Van Oijen
JLJacob Lewis
Jacob Lewis

4 July 2019 in Biophysical Reviews
Verified
Journal Article
Closed access
PDF file
SMStefan H. Mueller
Stefan H. Mueller
LSLisanne M. Spenkelink
Lisanne M. Spenkelink
AOAntoine M. Van Oijen
Antoine M. Van Oijen

18 June 2025 in Communications Biology
Verified
Journal Article
Open access
PDF file
JCJordan H. Cater
Jordan H. Cater
NSNehad S. El Salamouni
Nehad S. El Salamouni
GMGhada H. Mansour
Ghada H. Mansour
SHSebastian Hutchinson
Sebastian Hutchinson
CGConall Mc Guinness
Conall Mc Guinness
LSLisanne M. Spenkelink
Lisanne M. Spenkelink
Quenchbodies, antibodies labelled with fluorophores that increase in intensity upon antigen binding, offer great promise for biosensor development. Nanobody-based quenchbodies are particularly attractive due to their small size, ease of expression, high stability, rapid evolvability, and amenability to protein engineering. However, existing designs for protein detection show limited dynamic range, with fluorescence increases of only 1.1–1.4 fold. Here we identify the tryptophan residues in the nanobody complementarity-determining regions (CDRs) that are critical to quenchbody performance. Using a combination of rational design and molecular dynamics simulations, we developed an optimised nanobody scaffold with tryptophans introduced at key positions. We used this scaffold in an in vitro directed-evolution screen against human inflammatory cytokine interleukin-6 (IL-6). This yielded quenchbodies with 1.5–2.4-fold fluorescence increases, enabling IL-6 detection down to 1–2 nM. Our scaffold provides a valuable platform for developing biosensors for diverse protein targets, with applications in research, diagnostics, and environmental monitoring.